| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.28 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |